{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:52:19Z","timestamp":1790985139720,"version":"4.1.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Although brain-derived neurotrophic factor (BDNF)has garnered extensive attention as a neuroendocrine marker in schizophrenia (SZ), its clinical utility remains limite due to inconsistent findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To address this gap, serum samples were collected from 24 female patients with SZ and 25 healthy controls. The metabolic profiling was performed using gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) to capture abroad range of metabolites.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our results revealed that BDNF is not a robust discriminatory biomarker. Marked differences in metabolic profiles were identified between patients with SZ and healthy individuals. The GC-MS analysis revealed significant differences in 79 metabolites; while the LC-MS analysis identified 419 significantly differential metabolites. Functional analysis reveals that these differential metabolites predominantly contribute to metabolic and neuro-related processes. Our findings demonstrate that norepinephrine and melatonin, two additional neuroendocrine compounds, are significantly elevated in patients with SZ compared to healthy controls. Notably, their higher areas under the curve (AUC) values compared to BDNF highlight their potential as more reliable biomarkers for SZ.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study offers valuable insights into the altered metabolic patterns of female patients with SZ and establishes melatonin and norepinephrine as promising neuroendocrine biomarkers, underscoring their diagnostic value and role in the neuroendocrine regulation of mental disorders.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1551172","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T04:14:32Z","timestamp":1746072872000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Neuroendocrine characterization into schizophrenia: norepinephrine and melatonin as promising biomarkers"],"prefix":"10.3389","volume":"16","author":[{"given":"Junwei","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiechun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2012.00392","article-title":"Cognition-emotion dysinteraction in schizophrenia","volume":"3","author":"Anticevic","year":"2012","journal-title":"Front Psychol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sby112","article-title":"Salience-default mode functional network connectivity linked to positive and negative symptoms of schizophrenia (vol 45, pg 892, 2018)","volume":"45","author":"Hare","year":"2019","journal-title":"Schizophr Bull"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.1017865","article-title":"Mimicking effects of auditory verbal hallucinations on language production at the level of words, sentences and stories","volume":"16","author":"Heim","year":"2022","journal-title":"Front Psychol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr Bull"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbs130","article-title":"A systematic review and meta-analysis of recovery in schizophrenia","volume":"39","author":"Jaaskelainen","year":"2013","journal-title":"Schizophr Bull"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.22m14458","article-title":"The economic burden of schizophrenia in the United States","volume":"83","author":"Kadakia","year":"2022","journal-title":"J Clin Psychiat"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852916000316","article-title":"Psychotic disorders in DSM-5 and ICD-11","volume":"21","author":"Biedermann","year":"2016","journal-title":"CNS Spectrums"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.24869\/psyd.2020.320","article-title":"Classification and diagnosis of schizophrenia or other primary psychotic disorders: changes from icd-10 to icd-11 and implementation in clinical practice","volume":"32","author":"Gaebel","year":"2020","journal-title":"Psychiat Danub"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60995-8","article-title":"Schizophrenia","volume":"374","author":"van Os","year":"2009","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.17691\/stm","article-title":"Diagnosis of schizophrenia based on the data of various modalities: biomarkers and machine learning techniques (Review)","volume":"14","author":"Sharaev","year":"2022","journal-title":"Sovrem Tehnol Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.scog.2023.100286","article-title":"Differences in social perception in people with schizophrenia and bipolar disorder","volume":"33","author":"Cavieres","year":"2023","journal-title":"Schizophr Res-Cogn"},{"key":"B12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2174\/1381612825666191216153508","article-title":"Specificity and continuity of schizophrenia and bipolar disorder: relation to biomarkers","volume":"26","author":"Yamada","year":"2020","journal-title":"Curr Pharm Design"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.3191","article-title":"Inflammatory biomarkers and risk of schizophrenia A 2-sample mendelian randomization study","volume":"74","author":"Hartwig","year":"2017","journal-title":"JAMA Psychiat"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18040733","article-title":"Theranostic biomarkers for schizophrenia","volume":"18","author":"Perkovic","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911324","article-title":"Cytokine imbalance as a biomarker of treatment-resistant schizophrenia","volume":"23","author":"Shnayder","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.schres.2014.07.025","article-title":"Neuroimmune biomarkers in schizophrenia","volume":"176","author":"Tomasik","year":"2016","journal-title":"Schizophr Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3934\/Neuroscience.2023002","article-title":"Brain-derived neurotrophic factor (BDNF) in schizophrenia research: a quantitative review and future directions","volume":"10","author":"Ahmad","year":"2023","journal-title":"AIMS Neurosci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.876749","article-title":"Dysbindin-1, BDNF, and GABAergic transmission in schizophrenia","volume":"13","author":"Jun","year":"2022","journal-title":"Front Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-derived neurotrophic factor: A key molecule for memory in the healthy and the pathological brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"122282","DOI":"10.1016\/j.lfs.2023.122282","article-title":"TrkB\/BDNF signaling pathway and its small molecular agonists in CNS injury","volume":"336","author":"Wang","year":"2024","journal-title":"Life Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212373","article-title":"Accuracy of brain-derived neurotrophic factor levels for differentiating between Taiwanese patients with major depressive disorder or schizophrenia and healthy controls","volume":"14","author":"Chiou","year":"2019","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2010.88","article-title":"Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis","volume":"16","author":"Green","year":"2011","journal-title":"Mol Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/13651501.2022.2035770","article-title":"Brain-Derived neurotrophic factor (BDNF) plasma level increases in patients with resistant schizophrenia treated with electroconvulsive therapy (ECT)","volume":"26","author":"Shahin","year":"2022","journal-title":"Int J Psychiatry Clin Pract"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2003.08.004","article-title":"Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls","volume":"351","author":"Shimizu","year":"2003","journal-title":"Neurosci Lett"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2019.04.015","article-title":"Increased plasma Brain-Derived Neurotrophic Factor (BDNF) levels in females with schizophrenia","volume":"209","author":"Weickert","year":"2019","journal-title":"Schizophr Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"10.1111","DOI":"10.1111\/jne.2016.28.issue-7","article-title":"Neuroendocrine regulation of anxiety: beyond the hypothalamic-pituitary-adrenal axis","volume":"28","author":"Borrow","year":"2016","journal-title":"J Neuroendocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2005.08.007","article-title":"Role of brain norepinephrine in the behavioral response to stress","volume":"29","author":"Morilak","year":"2005","journal-title":"Prog Neuro-Psychoph"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2015.11.024","article-title":"Differential cognitive actions of norepinephrine \u03b12 and \u03b11 receptor signaling in the prefrontal cortex","volume":"1641","author":"Berridge","year":"2016","journal-title":"Brain Res"},{"key":"B29","first-page":"188","article-title":"Characteristics of cognitive impairment in patients with schizophrenia","volume":"51","author":"Hisnao","year":"2016","journal-title":"Int J Psychol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.neubiorev.2020.07.038","article-title":"The role of norepinephrine in the pathophysiology of schizophrenia","volume":"118","author":"M\u00e4ki-Marttunen","year":"2020","journal-title":"Neurosci Biobehav R"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2826.2003.00989.x","article-title":"Role of melatonin in the regulation of human circadian rhythms and sleep","volume":"15","author":"Cajochen","year":"2003","journal-title":"J Neuroendocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(20)30136-X","article-title":"Sleep disturbance and psychiatric disorders","volume":"7","author":"Freeman","year":"2020","journal-title":"Lancet Psychiat"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60095-0","article-title":"Novel melatonin-based therapies: potential advances in the treatment of major depression","volume":"378","author":"Hickie","year":"2011","journal-title":"Lancet"},{"key":"B34","first-page":"E408","article-title":"Brain sites mediating melatonin regulation of immune function and stress in siberian hamsters (Phodopus sungorus)","volume":"59","author":"Shor","year":"2019","journal-title":"Integr Comp Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm324","article-title":"LIPID MAPS online tools for lipid research","volume":"35","author":"Fahy","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000179845.53213.39","article-title":"METLIN: a metabolite mass spectral database","volume":"27","author":"Smith","year":"2005","journal-title":"Ther Drug Monit"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1089","article-title":"HMDB 4.0: the human metabolome database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.schres.2013.05.028","article-title":"Definition and description of schizophrenia in the DSM-5","volume":"150","author":"Tandon","year":"2013","journal-title":"Schizophr Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/bs.adgen.2016.08.001","article-title":"Genetics of schizophrenia: historical insights and prevailing evidence","volume":"96","author":"van de Leemput","year":"2016","journal-title":"Adv Genet"},{"key":"B40","article-title":"Physiology of the pineal gland and melatonin","volume-title":"Endotext","author":"Arendt","year":"2000"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/biof.v35:2","article-title":"Melatonin: signaling mechanisms of a pleiotropic agent","volume":"35","author":"Hardeland","year":"2009","journal-title":"Biofactors"},{"key":"B42","doi-asserted-by":"publisher","first-page":"112322","DOI":"10.1016\/j.jphotobiol.2021.112322","article-title":"Mel1b and Mel1c melatonin receptors mediate green light-induced secretion of growth hormone in chick adenohypophysis cells via the AC\/PKA and ERK1\/2 signalling pathways","volume":"225","author":"Liu","year":"2021","journal-title":"J Photochem Photobiol B Dec"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.10605","article-title":"Melatonin regulates neuronal plasticity in the hippocampus","volume":"72","author":"El-Sherif","year":"2003","journal-title":"J Neurosci Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1006\/frne.2000.0202","article-title":"Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry","volume":"22","author":"Pacchierotti","year":"2001","journal-title":"Front Neuroendocrinol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(84)90093-3","article-title":"Melatonin immunoreactivity in cerebrospinal-fluid of schizophrenic-patients and healthy controls","volume":"11","author":"Beckmann","year":"1984","journal-title":"Psychiat Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v11.i8.463","article-title":"Therapeutic use of melatonin in schizophrenia: A systematic review","volume":"11","author":"Duan","year":"2021","journal-title":"World J Psychiatr"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2015.09.039","article-title":"Organization of the locus coeruleus-norepinephrine system","volume":"25","author":"Schwarz","year":"2015","journal-title":"Curr Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2013.00003","article-title":"Rapid glucocorticoid-induced activation of TRP and CB1 receptors causes biphasic modulation of glutamate release in gastric-related hypothalamic preautonomic neurons","volume":"7","author":"Boychuk","year":"2013","journal-title":"Front Neurosci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.8.1227","article-title":"CSF norepinephrine concentrations in posttraumatic stress disorder","volume":"158","author":"Geracioti","year":"2001","journal-title":"Am J Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2017.00042","article-title":"The role of norepinephrine and its alpha-adrenergic receptors in the pathophysiology and treatment of major depressive disorder and schizophrenia: A systematic review","volume":"8","author":"Maletic","year":"2017","journal-title":"Front Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.psychres.2014.01.011","article-title":"Is elevated norepinephrine an etiological factor in some cases of schizophrenia","volume":"215","author":"Fitzgerald","year":"2014","journal-title":"Psychiatry Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2017.00042","article-title":"The role of norepinephrine and its \u03b1-adrenergic receptors in the pathophysiology and treatment of major depressive disorder and schizophrenia: A systematic review","volume":"17","author":"Maletic","year":"2017","journal-title":"Front Psychiatry"},{"key":"B53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00213-003-1724-3","article-title":"Adrenergic targets for the treatment of cognitive deficits in schizophrenia","volume":"174","author":"Arnsten","year":"2004","journal-title":"Psychopharmacology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"63","DOI":"10.31887\/DCNS.2018.20.1\/bpenninx","article-title":"Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications","volume":"20","author":"Penninx","year":"2018","journal-title":"Dialogues Clin Neurosci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"152369","DOI":"10.1016\/j.comppsych.2023.152369","article-title":"Associations between metabolic disorders and sleep disturbance in patients with schizophrenia","volume":"122","author":"Yan","year":"2023","journal-title":"Compr Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-006-9062-8","article-title":"Glutamate and schizophrenia: beyond the dopamine hypothesis","volume":"26","author":"Coyle","year":"2006","journal-title":"Cell Mol Neurobiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.2019.73.issue-5","article-title":"Glutamate hypothesis in schizophrenia","volume":"73","author":"Uno","year":"2019","journal-title":"Psychiatry Clin Neurosci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2021.2006514","article-title":"Neuroinflammation and oxidative stress in schizophrenia: are these opportunities for repurposing","volume":"134","author":"Ansari","year":"2022","journal-title":"Postgrad Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2006.05.028","article-title":"Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons","volume":"19","author":"Chen","year":"2007","journal-title":"Cell Signal"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2007.10.016","article-title":"Insulin modulates norepinephrine-mediated melatonin synthesis in cultured rat pineal gland","volume":"82","author":"Garcia","year":"2008","journal-title":"Life Sci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9050466","article-title":"SIRT1-dependent upregulation of BDNF in human microglia challenged with A\u03b2: an early but transient response rescued by melatonin","volume":"9","author":"Caruso","year":"2021","journal-title":"Biomedicines"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1551172\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T04:14:34Z","timestamp":1746072874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1551172\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":61,"alternative-id":["10.3389\/fendo.2025.1551172"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1551172","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"article-number":"1551172"}}